Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Trinity Bio ADR (TRIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 133,013
  • Shares Outstanding, K 23,710
  • Annual Sales, $ 99,610 K
  • Annual Income, $ -100,630 K
  • 36-Month Beta 1.14
  • Price/Sales 1.34
  • Price/Cash Flow 5.17
  • Price/Book 0.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.32 +5.45%
on 03/24/17
6.19 -9.37%
on 03/31/17
-0.01 (-0.18%)
since 03/21/17
3-Month
5.20 +7.88%
on 03/14/17
6.87 -18.34%
on 01/26/17
-1.26 (-18.34%)
since 01/20/17
52-Week
5.20 +7.88%
on 03/14/17
13.68 -58.99%
on 08/29/16
-5.78 (-50.75%)
since 04/21/16

Most Recent Stories

More News
Trinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter...

TRIB : 5.61 (-0.18%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB). Such investors are...

TRIB : 5.61 (-0.18%)
INVESTOR ALERT: Glancy Prongay & Murray Commences Investigation on Behalf of Trinity Biotech plc Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of investors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB) concerning the Company...

TRIB : 5.61 (-0.18%)
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter...

TRIB : 5.61 (-0.18%)
The Top 200 IVD Companies Worldwide

Did you know?

TRIB : 5.61 (-0.18%)
CEMI : 6.05 (+0.83%)
OSUR : 12.67 (+0.24%)
Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Trinity Biotech plc (NASDAQ:TRIB) concerning possible violations of the federal securities laws.

TRIB : 5.61 (-0.18%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity Biotech plc and Certain Officers and Directors -- TRIB

Levi & Korsinsky, LLP announces that it has commenced an investigation of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB) concerning possible violations of federal securities laws by the...

TRIB : 5.61 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Support & Resistance

2nd Resistance Point 5.72
1st Resistance Point 5.67
Last Price 5.61
1st Support Level 5.56
2nd Support Level 5.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.